Consun Pharmaceutical Group Limited (HKG:1681)
13.04
-0.12 (-0.91%)
Sep 11, 2026, 4:08 PM HKT
HKG:1681 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, HKG:1681 stock has a consensus rating of "Buy" and an average price target of $22.90. The average 1-year stock price forecast is 75.61% higher than the current stock price, while the lowest is $19.22 (+47.39%) and the highest is $26.83 (+105.75%).
Price Target: $22.90 (+75.61%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:1681 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | Aug '25 | Sep '25 | Mar '26 | Apr '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $19.16 | Buy | Maintains | $19.16 | +46.93% | Aug 30, 2026 |
Unknown Analyst China Everbright No rating | China Everbright | Buy Maintains $17.73 | Buy | Maintains | $17.73 | +35.97% | Jul 2, 2026 |
Unknown Analyst First Shanghai Securities No rating | First Shanghai Securities | Buy Maintains $25.30 | Buy | Maintains | $25.30 | +94.02% | Apr 16, 2026 |
| DBS | DBS | Buy Maintains $26.00 | Buy | Maintains | $26.00 | +99.39% | Mar 27, 2026 |
Financial Forecast
Revenue This Year
3.88B
from 3.42B
Increased by 13.60%
Revenue Next Year
4.35B
from 3.88B
Increased by 12.07%
EPS This Year
1.47
from 1.26
Increased by 16.89%
EPS Next Year
1.62
from 1.47
Increased by 10.07%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.